Navigation Links
Particle size matters to bacteria ability to immobilize heavy metals

One of the most common bacteria in the Earth, Shewanella oneidensis MR-1, uses oxygen as an energy source for respiration. But in the absence of oxygen, Shewanella uses (oxy)hydroxide minerals. These metal particles may also have adsorbed heavy metals on them. As a result, Shewanella influence the mobility and bioavailability of iron and environmental contaminants like lead, cobalt, and arsenic.

Ph.D. student Saumyaditya Bose and Professor Michael Hochella Jr., both in geosciences in the College of Science at Virginia Tech, and their research colleagues at Pacific Northwest National Laboratory (PNNL), are looking at how the size of iron oxide nano particles influences the bacteria's ability to breathe. This is the first study by any group that couples environmental microbiology and nano-mineralogy.

"This adds to our understanding of how nanoparticles might influence the environment and contaminant metal mobility in our rivers, lakes and other surface waters, as well as groundwater," said Bose.

He will present the research at the 232nd National Meeting of the American Chemical Society on September 10-14 in San Francisco.

Using iron oxide nanoparticles (less than 100 nm), which are common and the most used transition metal oxide for bacterial respiration, the researchers are looking at the interfacial reactions between the whole bacterial cell and the particles to determine the influence of mineral size on microbial reduction rates at the nanoscale. The researchers are looking at microbial reduction of nano hematite, which Bose synthesized in the lab and characterized.

"Nano particles of iron oxides are present everywhere and, due to their small size but large surface area, they provide bacteria a large amount of reactive sites," said Bose. "These particles are reduced by biological and non-biological methods. Different metals, including toxic heavy meals, are adsorbed onto these nanoparticles. When the iron oxides precipi
'"/>

Source:Virginia Tech


Page: 1 2 3

Related biology news :

1. Size matters: Preventing large mammal extinction
2. Space matters: Estimating species diversity in the fossil record
3. Bigger brain size matters for intellectual ability
4. UCSB researchers discover shape matters to macrophages
5. Researchers find that bumblebees flower choice matters
6. For Pacific white shrimp, gender matters when competing for food
7. The penalty of having a sister -- why sibling sex matters for male saiga antelopes
8. Anti-bacterial additive widespread in U.S. waterways
9. A bacterial genome reveals new targets to combat infectious disease
10. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
11. Scientists discover that host cell lipids facilitate bacterial movement
Post Your Comments:
Breaking Biology Technology:Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6